Covered recipient · General Payments record
TAMAR C CARMEL
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2022
$8,089.72
- Reported across 73 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $3,741.50 | 2 |
| Food and Beverage | $99.05 | 7 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | $2,008.68 | 3 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,741.50 | 1 |
| ABBVIE INC. | $44.07 | 2 |
| Virtus Pharmaceuticals LLC | $18.07 | 1 |
| Hologic Sales and Service, LLC | $15.30 | 1 |
| Otsuka America Pharmaceutical, Inc. | $12.93 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.36 | 03/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 890709015 | CMS |
| ABBVIE INC. | $25.71 | 04/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 890709017 | CMS |
| Hologic, LLC | $15.30 | 03/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 877655341 | CMS |
| Otsuka America Pharmaceutical, Inc. | $12.93 | 04/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | 929270129 | CMS |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,741.50 | 06/07/2022 | Consulting Fee | Undisputed | 01/23/2026 | 933755701 | CMS |
| Sunovion Pharmaceuticals Inc. | $5.11 | 03/31/2022 | Food and Beverage | Undisputed | 01/23/2026 | 921158761 | CMS |
| Sunovion Pharmaceuticals Inc. | $3.57 | 04/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | 921171621 | CMS |
| Sunovion Pharmaceuticals Inc. | $2,000.00 | 06/16/2022 | Consulting Fee | Undisputed | 01/23/2026 | 921187467 | CMS |
| Virtus Pharmaceuticals LLC | $18.07 | 03/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 901465133 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.